BR9708864A - Composto composição farmacêutica e processo para o tratamento ou a prevenção de uma infecção bacteriana em um paciente mamífero - Google Patents
Composto composição farmacêutica e processo para o tratamento ou a prevenção de uma infecção bacteriana em um paciente mamíferoInfo
- Publication number
- BR9708864A BR9708864A BR9708864A BR9708864A BR9708864A BR 9708864 A BR9708864 A BR 9708864A BR 9708864 A BR9708864 A BR 9708864A BR 9708864 A BR9708864 A BR 9708864A BR 9708864 A BR9708864 A BR 9708864A
- Authority
- BR
- Brazil
- Prior art keywords
- prevention
- treatment
- pharmaceutical composition
- bacterial infection
- mammalian patient
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
- C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
- C07D477/14—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1618496P | 1996-04-24 | 1996-04-24 | |
| GBGB9609741.5A GB9609741D0 (en) | 1996-05-10 | 1996-05-10 | Carbapenem antibacterial compounds compositions containing such componds and methods of treatment |
| PCT/US1997/006626 WO1997040048A1 (en) | 1996-04-24 | 1997-04-21 | Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9708864A true BR9708864A (pt) | 1999-08-03 |
Family
ID=26309297
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9708864A BR9708864A (pt) | 1996-04-24 | 1997-04-21 | Composto composição farmacêutica e processo para o tratamento ou a prevenção de uma infecção bacteriana em um paciente mamífero |
Country Status (31)
| Country | Link |
|---|---|
| EP (1) | EP0906313B1 (pt) |
| JP (1) | JP3176068B2 (pt) |
| KR (1) | KR20000010599A (pt) |
| CN (1) | CN1074767C (pt) |
| AR (1) | AR006810A1 (pt) |
| AT (1) | ATE260915T1 (pt) |
| AU (1) | AU707459B2 (pt) |
| BG (1) | BG102949A (pt) |
| BR (1) | BR9708864A (pt) |
| CA (1) | CA2252402C (pt) |
| CO (1) | CO4990968A1 (pt) |
| CZ (1) | CZ340798A3 (pt) |
| DE (1) | DE69727931T2 (pt) |
| EA (1) | EA001296B1 (pt) |
| EE (1) | EE03689B1 (pt) |
| ES (1) | ES2216142T3 (pt) |
| HK (1) | HK1021186A1 (pt) |
| HR (1) | HRP970213A2 (pt) |
| HU (1) | HUP9901778A3 (pt) |
| ID (1) | ID16662A (pt) |
| IL (1) | IL126480A0 (pt) |
| IS (1) | IS4861A (pt) |
| NO (1) | NO984949L (pt) |
| NZ (1) | NZ332183A (pt) |
| PE (1) | PE64298A1 (pt) |
| PL (1) | PL186881B1 (pt) |
| SK (1) | SK283550B6 (pt) |
| TR (1) | TR199802140T2 (pt) |
| TW (1) | TW539677B (pt) |
| WO (1) | WO1997040048A1 (pt) |
| YU (1) | YU46298A (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6406457B1 (en) | 1994-03-02 | 2002-06-18 | Scimed Life Systems, Inc. | Block copolymer elastomer catheter balloons |
| US7163522B1 (en) | 1994-03-02 | 2007-01-16 | Scimed Life Systems, Inc. | Block copolymer elastomer catheter balloons |
| WO1998051677A1 (en) * | 1997-05-13 | 1998-11-19 | Merck & Co., Inc. | Process for synthesizing carbapenem intermediates |
| US5908936A (en) * | 1997-05-13 | 1999-06-01 | Merck & Co., Inc. | Process for synthesizing carbapenem intermediates |
| JP2002509856A (ja) * | 1997-10-23 | 2002-04-02 | メルク エンド カムパニー インコーポレーテッド | カルバペネム系抗菌化合物、組成物および治療方法 |
| AU752313B2 (en) * | 1997-10-23 | 2002-09-12 | Merck & Co., Inc. | Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| US6140318A (en) | 1997-10-23 | 2000-10-31 | Merck & Co., Inc. | Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| US6271222B1 (en) * | 1998-05-28 | 2001-08-07 | Merck & Co., Inc. | Penem antibacterial compounds, compositions and methods of treatment |
| EP1104424B1 (en) * | 1998-06-17 | 2004-04-07 | Merck & Co., Inc. | Process for the synthesis of carbapenem intermediates |
| AU4711799A (en) * | 1998-06-25 | 2000-01-10 | Merck & Co., Inc. | (heterocyclic) methyl substituted carbapenem antibacterials |
| JP2002518446A (ja) * | 1998-06-25 | 2002-06-25 | メルク エンド カムパニー インコーポレーテッド | カルバペネム抗菌性化合物、前記化合物を含む組成物及び治療方法 |
| US7672747B2 (en) | 2000-03-30 | 2010-03-02 | Lam Research Corporation | Recipe-and-component control module and methods thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0429341A3 (en) * | 1989-11-20 | 1991-11-13 | Rhone-Poulenc Sante | Heterocyclic derivatives, their preparation and pharmaceuticals containing them |
| FR2661177A1 (fr) * | 1990-04-23 | 1991-10-25 | Rhone Poulenc Sante | Derives du naphtosultame antagonistes de la serotonine, leur preparation et les medicaments les contenant. |
| US5451579A (en) * | 1994-02-15 | 1995-09-19 | Merck & Co., Inc. | 1-β-methyl-carbapenem, compositions containing same and methods of use |
-
1997
- 1997-04-21 JP JP53823697A patent/JP3176068B2/ja not_active Expired - Fee Related
- 1997-04-21 NZ NZ332183A patent/NZ332183A/xx unknown
- 1997-04-21 AU AU24629/97A patent/AU707459B2/en not_active Ceased
- 1997-04-21 TR TR1998/02140T patent/TR199802140T2/xx unknown
- 1997-04-21 EP EP97920438A patent/EP0906313B1/en not_active Expired - Lifetime
- 1997-04-21 EA EA199800949A patent/EA001296B1/ru not_active IP Right Cessation
- 1997-04-21 SK SK1454-98A patent/SK283550B6/sk unknown
- 1997-04-21 WO PCT/US1997/006626 patent/WO1997040048A1/en not_active Application Discontinuation
- 1997-04-21 IL IL12648097A patent/IL126480A0/xx unknown
- 1997-04-21 CN CN97195741A patent/CN1074767C/zh not_active Expired - Fee Related
- 1997-04-21 ES ES97920438T patent/ES2216142T3/es not_active Expired - Lifetime
- 1997-04-21 PL PL97329376A patent/PL186881B1/pl not_active IP Right Cessation
- 1997-04-21 DE DE69727931T patent/DE69727931T2/de not_active Expired - Lifetime
- 1997-04-21 BR BR9708864A patent/BR9708864A/pt not_active IP Right Cessation
- 1997-04-21 EE EE9800355A patent/EE03689B1/xx not_active IP Right Cessation
- 1997-04-21 AT AT97920438T patent/ATE260915T1/de not_active IP Right Cessation
- 1997-04-21 CA CA002252402A patent/CA2252402C/en not_active Expired - Fee Related
- 1997-04-21 YU YU46298A patent/YU46298A/sh unknown
- 1997-04-21 HU HU9901778A patent/HUP9901778A3/hu unknown
- 1997-04-21 KR KR1019980708482A patent/KR20000010599A/ko not_active Application Discontinuation
- 1997-04-21 CZ CZ983407A patent/CZ340798A3/cs unknown
- 1997-04-22 PE PE1997000306A patent/PE64298A1/es not_active Application Discontinuation
- 1997-04-22 HR HR9609741.5A patent/HRP970213A2/xx not_active Application Discontinuation
- 1997-04-23 TW TW086105293A patent/TW539677B/zh active
- 1997-04-23 AR ARP970101648A patent/AR006810A1/es not_active Application Discontinuation
- 1997-04-23 ID IDP971350A patent/ID16662A/id unknown
- 1997-04-24 CO CO97021827A patent/CO4990968A1/es unknown
-
1998
- 1998-10-06 IS IS4861A patent/IS4861A/is unknown
- 1998-10-23 NO NO984949A patent/NO984949L/no not_active Application Discontinuation
- 1998-11-23 BG BG102949A patent/BG102949A/bg unknown
-
2000
- 2000-01-10 HK HK00100158A patent/HK1021186A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9500659A (pt) | Composto composição farmacêutica e método de tratamento ou prevenção de uma condição causada por uma injeção bacteriana | |
| BR9407799A (pt) | Composição de matéria método de tratamento e composição farmaceutica | |
| BR9406178A (pt) | Composição de amino-açucar e glicosaminoglicano para o tratamento e restauração de tecido conectivo | |
| BR9407869A (pt) | Combinaçao composiçao farmacêutica e processo para o tratamento de osteoporose | |
| BR9407720A (pt) | Composto composiçao farmacêutica e processo para a prevençao ou tratamento de pertubaçoes imunorreguladoras ou doenças que compreendem a administraçao do composto | |
| BR9406128A (pt) | Uso de um composto processo para o tratamento e/ou prevençao de distúrbios psicóticos composto composiçao farmacêutica processos para a preparaçao de um composto e de uma composiçao farmacêutica | |
| BR9508586A (pt) | Compostos processo de preparação dos mesmos uso dos mesmos processo de tratamento de uma condição clínica em um mamífero e composição farmacêutica | |
| BR9408148A (pt) | Processo para tratamento de arritmia composto e formulação farmacêutica | |
| BR9504072A (pt) | Composiçao farmacêutica métodos para o tratamento de hipercolesterolemia de aterosclerose e kit | |
| BR9602542A (pt) | Composto método para o tratamento de uma doença dependente da fosforilase de glicogénio composição farmacéutica e processo para a preparação de um composto | |
| BR9608500A (pt) | Utilização de pelo menos um extrato de pelo menos uma bactéria filamentosa não fotossintética composição cosmética ou farmacêutica e processo de tratamento cosméstico | |
| BR9709915A (pt) | Composto composição farmacêutica utilização do composto e processos para o tratamento ou a prevençao de distúrbios fisiológicos asociados com um excesso de taquiquininas e para preparação do composto | |
| BR9506581A (pt) | Composto composição farmacêutica uso do composto processo para a profilaxia ou tratamento de uma condição clínica em um manífero por exemplo um humano e para a preparação de um composto e composto intermediário | |
| EE9800234A (et) | Ravimeetod ja farmatseutiline kompositsioon | |
| BR9708607A (pt) | Composto composição farmacéutica utilização de um composto processo para tratamento ou redução do risco de doença inflamatória num paciente e para a preparação de um composto e intermediário químico | |
| BR9607599A (pt) | Ifn-con qumicamente modificado composição farmacêutica preparação processo de tratamento de um paciente possuindo uma condição tratável com ifn-con e processo de liberação de um interferon | |
| BR9502471A (pt) | Composto de guanidina processo para preparar um composto de guanidina composição farmaceutica uso de um composto de guanidina método para o tratamento profilático ou terapêutico de doenças e processo para preparar uma composição farmacêutica | |
| BR9708864A (pt) | Composto composição farmacêutica e processo para o tratamento ou a prevenção de uma infecção bacteriana em um paciente mamífero | |
| BR9708930A (pt) | Composto derivado de 3-descladinose-2,3-anidro-eritromicina ou um seu sal ou éster farmaceuticamente aceitável processo para a preparação do composto composição farmacêutica e processo de tratamento de infecções bacterianas | |
| BR9710376A (pt) | Composto antiviral uso do mesmo composi-Æo farmac-utica e processo para tratamento antiviral profil tico ou terap-utico de um animal humano ou nÆo humano | |
| BR9106377A (pt) | Composicao e processo para o tratamento topico de tecido lesado ou enfermo | |
| BR9710250A (pt) | Composto composição farmacêutica e processos para tratar uma infecção bacteriana em um paciente em necessidade de tal tratamento e para produzir um composto de bromotiacumicina | |
| DE69625883D1 (de) | Zusammensetzung zur Reinigung und/oder Desinfektion von medizinischen Geräten | |
| BR9510015A (pt) | Composto composição farmacéutica e processo para o tratamento de doenças enfecciosas em terapia humana ou veterinária | |
| BR9710544A (pt) | M-todo de tratamento composto e composi-Æo farmac-utica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A E 9A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1838 DE 28/03/2006. |